Fig. 2From: Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancerBreakdown of mutations and copy number alterations in DDR pathways. The overall proportion of mutations and copy number alterations were similar for localized and metastatic prostate cancerBack to article page